{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:50:33Z","timestamp":1791417033652,"version":"4.3.3"},"reference-count":12,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jaad.2025.02.086","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T11:56:58Z","timestamp":1741175818000},"page":"82-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Sofpironium topical gel, 12.45%, for the treatment of axillary hyperhidrosis: Pooled efficacy and safety results from 2 phase 3 randomized, controlled, double-blind studies"],"prefix":"10.1016","volume":"93","author":[{"given":"David","family":"Pariser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dee Anna","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Del Rosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Nestor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Schlessinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelaide","family":"Hebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia S.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaad.2025.02.086_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/13543784.2022.2017880","article-title":"Sofpironium bromide: an investigational agent for the treatment of axillary hyperhidrosis","volume":"31","author":"Gregoriou","year":"2022","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"10.1016\/j.jaad.2025.02.086_bib2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/jocd.14378","article-title":"Treatment of axillary hyperhidrosis","volume":"21","author":"Arora","year":"2022","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.02.086_bib3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaad.2018.07.002","article-title":"Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials","volume":"80","author":"Glaser","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2025.02.086_bib4","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1007\/s13555-022-00838-3","article-title":"Hyperhidrosis: a review of recent advances in treatment with topical anticholinergics","volume":"12","author":"Wong","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"4","key":"10.1016\/j.jaad.2025.02.086_bib5","first-page":"s5","article-title":"Supplement Article: a novel drug delivery method: retrometabolic drug design","volume":"21","author":"Armstrong","year":"2022","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.02.086_bib6","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.jaad.2020.02.016","article-title":"Efficacy and safety of topical sofpironium bromide gel for the treatment of axillary hyperhidrosis: a phase II, randomized, controlled, double-blinded trial","volume":"82","author":"Kirsch","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2025.02.086_bib7","doi-asserted-by":"crossref","first-page":"410","DOI":"10.36849\/JDD.5569","article-title":"Hyperhidrosis disease severity measure-axillary (HDSM-Ax): evaluation of measurement performance","volume":"20","author":"Hobart","year":"2021","journal-title":"J Drugs Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2025.02.086_bib8","first-page":"707","article-title":"The hyperhidrosis disease severity measure-axillary: conceptualization and development of item content","volume":"17","author":"Kirsch","year":"2018","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.02.086_bib9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s40257-022-00743-7","article-title":"The impact of hyperhidrosis on quality of life: a review of the literature","volume":"24","author":"Parashar","year":"2023","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.02.086_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092412","article-title":"Elevated social stress levels and depressive symptoms in primary hyperhidrosis","volume":"9","author":"Gross","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jaad.2025.02.086_bib11","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jaad.2016.07.001","article-title":"The prevalence of anxiety and depression in patients with or without hyperhidrosis (HH)","volume":"75","author":"Bahar","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2025.02.086_bib12","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.3390\/pharmaceutics13122012","article-title":"Vehicles for drug delivery and cosmetic moisturizers: review and comparison","volume":"13","author":"Barnes","year":"2021","journal-title":"Pharmaceutics"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225003937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225003937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:09:22Z","timestamp":1791414562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225003937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0190962225003937"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.02.086","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sofpironium topical gel, 12.45%, for the treatment of axillary hyperhidrosis: Pooled efficacy and safety results from 2 phase 3 randomized, controlled, double-blind studies","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.02.086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}